Navigation Links
Sequent Medical, Inc. lanza el microcatéter VIA
Date:12/11/2012

ALISO VIEJO, California, 11 de diciembre de 2012 /PRNewswire/ -- Sequent Medical, Inc. ha anunciado hoy la recepción de la Marca CE para el microcatéter VIA™, además de iniciar la introducción comercial de su nueva gama de productos en mercados selectos.

VIA se usará para el suministro y despliegue del sistema de embolización de aneurisma WEB® de Sequent, que se usa para tratar los aneurismas cerebrales. VIA está disponible actualmente en dos modelos, VIA y VIA PLUS.

"El microcatéter VIA proporciona una combinación optima de propiedades para la colocación estable de WEB, retirada y navegación, y permitirá a los médicos tratar una amplia gama de aneurismas a través de WEB", afirmó el doctor y médico Werner Weber, responsable del Departamento de Radiología y Neuroradiología Intervencional de Klinikum Vest, Knappschaftskrankenhaus, Recklinghausen, Alemania.

"En combinación con las adiciones planeadas para nuestra plataforma WEB, VIA demuestra el compromiso en marcha de Sequent Medical para desarrollar una amplia gama de tecnologías innovadoras basadas en catéter para los especialistas neurovasculares y sus pacientes", comentó Tom Wilder, director general y consejero delegado.

Acerca de Sequent Medical, Inc.

Sequent Medical, Inc. (www.sequentmedical.com) es una compañía privada de instrumentos neurovasculares cuyo objetivo es el desarrollo de innovadoras tecnologías neurovasculares basadas en catéter. El sistema de embolización de aneurisma WEB y microcatéter VIA han recibido la Marca CE. No está disponible para su venta o uso en Estados Unidos. Sequent Medical Inc. tiene su sede central en Aliso Viejo, California, además de tener su sede de operaciones europeas en Bonn, Alemania.

Acerca del sistema de embolización de aneurisma WEB

Construido basándose en las bases de los muelles embólicos endovasculares, WEB es un dispositivo de embolización neurovascular intra-sacular de baja porosidad que se ha diseñado para servir como puente entre el cuello de un aneurisma intracraneal de tipo con rotura o sin rotura y promover la inmovilidad rápida de peri-procedimiento. WEB permite a los médicos tratar los aneurismas intracraneales con la familiaridad de una aproximación intra-sacular usando los biomateriales establecidos.


'/>"/>
SOURCE Sequent Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sequent Medical, Inc. Launches VIA Microcatheter
2. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
3. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
4. Barrack, Rodos & Bacine Files Class Action Lawsuit Against St. Jude Medical, Inc.
5. Nonin Medical, Inc. arbeitet bei Pulsoxymetrieangebot für 2net-Plattform für drahtlose Gesundheitslösungen mit Qualcomm Life zusammen
6. Nonin Medical, Inc. Collaborates with Qualcomm Life to Provide Pulse Oximetry for the 2net Platform for Wireless Health Solutions
7. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
8. Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
9. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
10. Boston Scientific to Acquire BridgePoint Medical, Inc.
11. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... ... its executive team as the President of its HealthBI division. McFarland will ... and contact centers. , “Scott is a utility player who balances his ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has introduced a ... When we’re born, Nature gives us a full supply of melanin – in the ... lose this natural glare-reducing pigment; however, around the age of thirty, we develop a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... the present, Mirixa Corporation recently unveiled the MirixaPro 6.0 platform. As the ... how medication management services are delivered. Based on industry research and market ...
(Date:9/19/2017)... ... September 19, 2017 , ... Back Pain Centers of ... back pain with a reputable physician in their area, announces the addition of ... as Nevada Spine Clinic was founded by board-certified spine surgeon, Jaswinder Grover, M.D. ...
(Date:9/19/2017)... ... 2017 , ... The ISO 9001 standard sets out the requirements for a ... and improve customer satisfaction. ISO 9001:2015 was released in 2015 and certified organizations have ... September 2018. , As described in this white paper , ISO ...
Breaking Medicine News(10 mins):